Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
30.8M
-
Shares change
-
+1.19M
-
Total reported value, excl. options
-
$2.35B
-
Value change
-
+$109M
-
Put/Call ratio
-
0.41
-
Number of buys
-
47
-
Number of sells
-
-46
-
Price
-
$76.25
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q4 2019
116 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q4 2019.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.8M shares
of 114M outstanding shares and own 26.92% of the company stock.
Largest 10 shareholders include Foresite Capital Management I, LLC (7.24M shares), Foresite Capital Management II, LLC (6.84M shares), FMR LLC (3.14M shares), VHCP Management II, LLC (1.79M shares), JS Capital Management LLC (1.67M shares), MORGAN STANLEY (1.09M shares), VANGUARD GROUP INC (1.04M shares), ALLIANCEBERNSTEIN L.P. (978K shares), WELLS FARGO & COMPANY/MN (928K shares), and LORD, ABBETT & CO. LLC (654K shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.